JSR adding European biologic manufacturing capacity in Geneva expansion
JSR Life Sciences is set to add European biologic bulk drug substance manufacturing by opening a new KBI Biopharma facility in Geneva.
Archives for October 27, 2020
Thermo sees ‘very, very’ significant cold-chain demand as COVID-19 vaccines enter endgame
Thermo Fisher Scientific is seeing “very, very significant demand” for its cold storage range as the race to get COVID-19 vaccines to market enters its closing stages.
Novavax to start US Phase 3 COVID-19 vaccine trial next month
Novavax’s Phase 3 COVID-19 vaccine trial in the UK has been expanded to 15,000 participants; while a 30,000 strong Phase 3 clinical trial is due to start in the US and Mexico next month.
MHRA starts rolling review for Moderna’s COVID-19 vaccine candidate
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has begun a rolling review of Moderna’s mRNA COVID-19 vaccine candidate.
Care Access Research, Lilly join on mobile COVID-19 trials
The clinical research solutions firm is joining forces with pharma giant Eli Lilly to manage mobile research of the monoclonal antibody LY-CoV555.